Mood Disorder Cohort Research Consortium (MDCRC) in Korea
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Mood Disorders
- Sponsor
- Korea University Anam Hospital
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- illness severity and change in patients by using Clinical Global Impression-Bipolar score
- Last Updated
- 7 years ago
Overview
Brief Summary
The Mood Disorder Cohort Research Consortium (MDCRC) study is designed as a naturalistic observational prospective cohort study for early-onset mood disorders (major depressive disorders, bipolar disorders type 1 and 2) in South Korea.
Detailed Description
The Mood Disorder Cohort Research Consortium (MDCRC) study is designed as a naturalistic observational prospective cohort study for early-onset mood disorders (major depressive disorders, bipolar disorders type 1 and 2) in South Korea. The study subjects consist of two populations: 1) patients with mood disorders under 25 years old and 2) patients with mood disorders within 2 years of treatment under 35 years old. After successful screening, the subjects are evaluated using baseline assessments and serial follow-up assessments at 3-month intervals. Between the follow-up assessments, subjects are dictated to check their own daily mood status before bedtime using the eMood chart application or a paper mood diary. In addition, wearable activity tracker(Fitbit charge series) is applied for data collection such as activity, sleep, and heart rate during every moments. At the regular visits every 3 months, inter-visit assessments are evaluated based on daily mood charts and interviews with patients. In addition to the daily mood chart, sleep quality, inter-visit major and minor mood episodes, stressful life events, and medical usage pattern with medical expenses are also assessed. Genomic DNA from blood is obtained for genomic analyses. From the MDCRC study, the clinical course, prognosis, and related factors of early-onset mood disorders can be clarified. The MDCRC is also able to facilitate translational research for mood disorders and provide a resource for the convergence study of mood disorders.
Investigators
Heon-Jeong Lee, MD, PhD
Professor
Korea University Anam Hospital
Eligibility Criteria
Inclusion Criteria
- •under 25 years old with mood disorder
- •under 35 years old with mood disorder within 2 years of treatment
Exclusion Criteria
- •patients with intellectual disability
- •patients with organic brain injury
- •patients have difficulty reading and understanding the Korean language
Outcomes
Primary Outcomes
illness severity and change in patients by using Clinical Global Impression-Bipolar score
Time Frame: 3months
Secondary Outcomes
- Scores of depressive symptoms as assessed by MADRS(3months)
- Activity(3months)
- Heart rate(3months)
- Sleep(3months)
- Scores of manic symptoms as assessed by YMRS(3months)
- Daily mood chart(3 months)
- average monthly cost of treatment for psychiatric, medical, dental, and oriental medicinal management(3months)